Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 3Recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Conditions

Leiomyoma 9Myoma 3Menorrhagia 3Pregnancy Complications 1Polyps 1Myofibroma 1Infertility 1Agnosia 1

Interventions

estradiol, norethindrone drug combination 9elagolix 7Estradiol 7asoprisnil 6Uterine Artery Embolization 5Norethindrone Acetate 5relugolix 4Uterine Myomectomy 3linzagolix 2Tranexamic Acid 2ziprasidone 1vilaprisan 1ulipristal 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Tobramycin 1Spironolactone 1Sevelamer 1Rocuronium 1Radiofrequency Ablation 1Progesterone 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Nifedipine 1Nafcillin 1Molindone 1Methylprednisolone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Menorrhagia × Uterine Myomectomy × Clear all
NCT02163525 2025-09-30

Post Market TRUST - U.S.A. Study

Acessa Health, Inc.

Phase NA Completed
114 enrolled

Leiomyoma, Menorrhagia, Myoma

NCT01563783 2023-02-01

TRUST

Acessa Health, Inc.

Phase NA Completed
84 enrolled

Leiomyoma, Menorrhagia, Myoma

NCT01750008 2018-11-20

LUSTOR

Acessa Health, Inc.

Phase NA Completed
51 enrolled

Leiomyoma, Menorrhagia, Myoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡